Brief: Biopharma company GENFIT agrees to buy Swiss company Versantis

Genfit SA

19/09/2022 06:34

Sept 19 (Reuters) - Genfit Sa  GNFT.PA :
    * GENFIT TO ACQUIRE CLINICAL-STAGE BIOPHARMACEUTICAL COMPANY
VERSANTIS, EXPANDING ITS PORTFOLIO IN LIVER DISEASES
    * THESE DEAL TERMS INCLUDE A PAYMENT OF CHF40 MILLION, AN
AGGREGATE OF CHF65 MILLION OF POTENTIAL ADDITIONAL PAYMENTS
CONTINGENT ON SUCCESSFUL CLINICAL AND REGULATORY MILESTONES
    * TO ACQUIRE ALL SHARE CAPITAL AND VOTING RIGHTS OF
VERSANTIS, A
PRIVATE SWISS-BASED CLINICAL STAGE BIOTECHNOLOGY COMPANY
    * CONTINUES DEVELOPMENT OF ITS OTHER PROGRAM EVALUATING NTZ
IN
ACLF, WITH A PRE-IND MEETING SCHEDULED WITH FDA IN COMING WEEKS,
FOLLOWING ENCOURAGING PHASE 1 DATA

Source text for Eikon:  ID:nGNX3Bn4Jh 
Further company coverage:  GNFT.PA 

 (Reporting by Sudip Kar-Gupta)
 ((sudip.kargupta@thomsonreuters.com;))